Cross-reactivity of antipneumococcal surface protein C (PspC) antibodies with different strains and evaluation of inhibition of human complement factor H and secretory IgA binding via PspC

Clinical and Vaccine Immunology

Volumn 19, Issue 4, 2012, Pages 499-507

  Moreno, Adriana T ^a   Oliveira, Maria Leonor S ^a   Ho, Paulo L ^a   Vadesilho, Cintia F M ^a   Palma, Giovana M P ^a   Ferreira, Jorge M C ^a   Ferreira, Daniela M ^b   Santos, Silvia R ^c   Martinez, Marina B ^c   Miyaji, Eliane N ^a  

^a INSTITUTO BUTANTAN   (Brazil)

^b LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; BACTERIUM ANTIBODY; COMPLEMENT FACTOR H; IMMUNOGLOBULIN G ANTIBODY; MICROORGANISM PROTEIN; PNEUMOCOCCAL SURFACE PROTEIN A; PNEUMOCOCCAL SURFACE PROTEIN C; PROTEIN VARIANT; SECRETORY IMMUNOGLOBULIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ANTIGEN ANTIBODY COMPLEX; ANTIGEN DETECTION; ARTICLE; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CONTROLLED STUDY; CROSS REACTION; FEMALE; FLOW CYTOMETRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN INDUCTION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS INHIBITION; SEQUENCE ANALYSIS; STRAIN DIFFERENCE; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PNEUMONIAE; WESTERN BLOTTING;

EID: 84859338605     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.05706-11     Document Type: Article

References (48)

1. Ardanuy C, et al. 2009. Epidemiology of invasive pneumococcal disease among adult patients in Barcelona before and after pediatric 7-valent pneumococcal conjugate vaccine introduction, 1997-2007. Clin. Infect. Dis. 48:57-64.
2. Balachandran P, Brooks-Walter A, Virolainen-Julkunen A, Hollingshead SK, Briles DE. 2002. Role of pneumococcal surface protein C in nasopharyngeal carriage and pneumonia and its ability to elicit protection against carriage of Streptococcus pneumoniae. Infect. Immun. 70:2526-2534. (Pubitemid 34408397)
3. Beernink PT, et al. 2011. A meningococcal factor H binding protein mutant that eliminates factor H binding enhances protective antibody responses to vaccination. J. Immunol. 186:3606-3614.
4. Brooks-Walter A, Briles DE, Hollingshead SK. 1999. The pspC gene of Streptococcus pneumoniae encodes a polymorphic protein, PspC, which elicits cross-reactive antibodies to PspA and provides immunity to pneumococcal bacteremia. Infect. Immun. 67:6533-6542.
5. Cheng Q, Finkel D, Hostetter MK. 2000. Novel purification scheme and functions for a C3-binding protein from Streptococcus pneumoniae. Biochemistry 39:5450-5457. (Pubitemid 30257086)
6. Croucher NJ, et al. 2011. Rapid pneumococcal evolution in response to clinical interventions. Science 331:430-434.
7. Darrieux M, et al. 2008. Recognition of pneumococcal isolates by antisera raised against PspA fragments from different clades. J. Med. Microbiol. 57:273-278. (Pubitemid 351358529)
8. Dave S, Brooks-Walter A, Pangburn MK, McDaniel LS. 2001. PspC, a pneumococcal surface protein, binds human factor H. Infect. Immun. 69:3435-3437. (Pubitemid 32332245)
9. Dave S, Carmicle S, Hammerschmidt S, Pangburn MK, McDaniel LS. 2004. Dual roles of PspC, a surface protein of Streptococcus pneumoniae, in binding human secretory IgA and factor H. J. Immunol. 173:471-477. (Pubitemid 38797374)
10. Dias CA, Teixeira LM, da Gloria Carvalho G, Beall B. 2007. Sequential multiplex PCR for determining capsular serotypes of pneumococci recovered from Brazilian children. J. Med. Microbiol. 56:1185-1188. (Pubitemid 47477190)
11. Dieudonne-Vatran A, et al. 2009. Clinical isolates of Streptococcus pneumoniae bind the complement inhibitor C4b-binding protein in a PspC allele-dependent fashion. J. Immunol. 182:7865-7877.
12. Elm C, Rohde M, Vaerman JP, Chhatwal GS, Hammerschmidt S. 2004. Characterization of the interaction of the pneumococcal surface protein SpsA with the human polymeric immunoglobulin receptor (hpIgR). Indian J. Med. Res. 119(Suppl.):61-65. (Pubitemid 39004448)
13. Ferreira DM, et al. 2009. Characterization of protective mucosal and systemic immune responses elicited by pneumococcal surface protein PspA and PspC nasal vaccines against a respiratory pneumococcal challenge in mice. Clin. Vaccine Immunol. 16:636-645.
14. Ferreira PC, et al. 2008. Immunization of mice with Lactobacillus casei expressing intimin fragments produces antibodies able to inhibit the adhesion of enteropathogenic Escherichia coli to cultivated epithelial cells. FEMS Immunol. Med. Microbiol. 54:245-254.
15. Hammerschmidt S, et al. 2007. The host immune regulator factor H interacts via two contact sites with the PspC protein of Streptococcus pneumoniae and mediates adhesion to host epithelial cells. J. Immunol. 178:5848-5858.
16. Hammerschmidt S, Talay SR, Brandtzaeg P, Chhatwal GS. 1997. SpsA, a novel pneumococcal surface protein with specific binding to secretory immunoglobulin A and secretory component. Mol. Microbiol. 25:1113-1124. (Pubitemid 27410190)
17. Hammerschmidt S, Tillig MP, Wolff S, Vaerman JP, Chhatwal GS. 2000. Species-specific binding of human secretory component to SpsA protein of Streptococcus pneumoniae via a hexapeptide motif. Mol. Microbiol. 36:726-736. (Pubitemid 30258855)
18. Hicks LA, et al. 2007. Incidence of pneumococcal disease due to nonpneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004. J. Infect. Dis. 196:1346-1354. (Pubitemid 351412007)
19. Hollingshead SK, Becker R, Briles DE. 2000. Diversity of PspA: mosaic genes and evidence for past recombination in Streptococcus pneumoniae. Infect. Immun. 68:5889-5900.
20. Iannelli F, Chiavolini D, Ricci S, Oggioni MR, Pozzi G. 2004. Pneumococcal surface protein C contributes to sepsis caused by Streptococcus pneumoniae in mice. Infect. Immun. 72:3077-3080. (Pubitemid 38542444)
21. Iannelli F, Oggioni MR, Pozzi G. 2002. Allelic variation in the highly polymorphic locus pspC of Streptococcus pneumoniae. Gene 284:63-71. (Pubitemid 34219401)
22. Janulczyk R, Iannelli F, Sjoholm AG, Pozzi G, Bjorck L. 2000. Hic, a novel surface protein of Streptococcus pneumoniae that interferes with complement function. J. Biol. Chem. 275:37257-37263. (Pubitemid 32002148)
23. Jarva H, et al. 2002. Streptococcus pneumoniae evades complement attack and opsonophagocytosis by expressing the pspC locus-encoded Hic protein that binds to short consensus repeats 8-11 of factor H. J. Immunol. 168:1886 -1894.
24. Kerr AR, et al. 2006. The contribution of PspC to pneumococcal virulence varies between strains and is accomplished by both complement evasion and complement-independent mechanisms. Infect. Immun. 74: 5319-5324. (Pubitemid 44300451)
25. Li J, Glover DT, Szalai AJ, Hollingshead SK, Briles DE. 2007. PspA and PspC minimize immune adherence and transfer of pneumococci from erythrocytes to macrophages through their effects on complement activation. Infect. Immun. 75:5877-5885. (Pubitemid 350207827)
26. Lu L, Ma Y, Zhang JR. 2006. Streptococcus pneumoniae recruits complement factor H through the amino terminus of CbpA. J. Biol. Chem. 281:15464-15474. (Pubitemid 43855139)
27. Lu L, et al. 2008. Species-specific interaction of Streptococcus pneumoniae with human complement factor H. J. Immunol. 181:7138-7146.
28. Moreno AT, et al. 2010. Immunization of mice with single PspA fragments induces antibodies capable of mediating complement deposition on different pneumococcal strains and cross-protection. Clin. Vaccine Immunol. 17:439-446.
29. O'Brien KL, et al. 2009. Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet 374: 893-902.
30. Ogunniyi AD, Grabowicz M, Briles DE, Cook J, Paton JC. 2007. Development of a vaccine against invasive pneumococcal disease based on combinations of virulence proteins of Streptococcus pneumoniae. Infect. Immun. 75:350-357. (Pubitemid 46047911)
31. Ogunniyi AD, et al. 2007. Contributions of pneumolysin, pneumococcal surface protein A (PspA), and PspC to pathogenicity of Streptococcus pneumoniae D39 in a mouse model. Infect. Immun. 75:1843-1851. (Pubitemid 46559453)
32. Ogunniyi AD, Woodrow MC, Poolman JT, Paton JC. 2001. Protection against Streptococcus pneumoniae elicited by immunization with pneumolysin and CbpA. Infect. Immun. 69:5997-6003. (Pubitemid 32885158)
33. Orihuela CJ, et al. 2009. Laminin receptor initiates bacterial contact with the blood brain barrier in experimental meningitis models. J. Clin. Invest. 119:1638-1646.
34. Pai R, Gertz RE, Beall B. 2006. Sequential multiplex PCR approach for determining capsular serotypes of Streptococcus pneumoniae isolates. J. Clin. Microbiol. 44:124-131. (Pubitemid 43100590)
35. Pimenta FC, et al. 2011. Serotype and genotype distributions of pneumococcal carriage isolates recovered from Brazilian children attending day-care centers. J. Med. Microbiol. 60:1455-1459.
36. Quin LR, Onwubiko C, Carmicle S, McDaniel LS. 2006. Interaction of clinical isolates of Streptococcus pneumoniae with human complement factor H. FEMS Microbiol. Lett. 264:98-103. (Pubitemid 44511060)
37. Quin LR, et al. 2007. Factor H binding to PspC of Streptococcus pneumoniae increases adherence to human cell lines in vitro and enhances invasion of mouse lungs in vivo. Infect. Immun. 75:4082-4087. (Pubitemid 47206307)
38. Ramos CR, Abreu PA, Nascimento AL, Ho PL. 2004. A high-copy T7 Escherichia coli expression vector for the production of recombinant proteins with a minimal N-terminal His-tagged fusion peptide. Braz J. Med. Biol. Res. 37:1103-1109. (Pubitemid 39172546)
39. Ren B, Szalai AJ, Hollingshead SK, Briles DE. 2004. Effects of PspA and antibodies to PspA on activation and deposition of complement on the pneumococcal surface. Infect. Immun. 72:114-122. (Pubitemid 38018168)
40. Ren B, Szalai AJ, Thomas O, Hollingshead SK, Briles DE. 2003. Both family 1 and family 2 PspA proteins can inhibit complement deposition and confer virulence to a capsular serotype 3 strain of Streptococcus pneumoniae. Infect. Immun. 71:75-85. (Pubitemid 36026006)
41. Ricci S, et al. 2011. The factor H-binding fragment of PspC as a vaccine antigen for the induction of protective humoral immunity against experimental pneumococcal sepsis. Vaccine 29:8241-8249.
42. Roche AM, King SJ, Weiser JN. 2007. Live attenuated Streptococcus pneumoniae strains induce serotype-independent mucosal and systemic protection in mice. Infect. Immun. 75:2469-2475. (Pubitemid 46744338)
43. Rosenow C, et al. 1997. Contribution of novel choline-binding proteins to adherence, colonization and immunogenicity of Streptococcus pneumoniae. Mol. Microbiol. 25:819-829. (Pubitemid 27397511)
44. Singleton RJ, et al. 2007. Invasive pneumococcal disease caused by nonvaccine serotypes among Alaska native children with high levels of 7-valent pneumococcal conjugate vaccine coverage. JAMA 297:1784-1792. (Pubitemid 46658647)
45. Smith BL, Hostetter MK. 2000. C3 as substrate for adhesion of Streptococcus pneumoniae. J. Infect. Dis. 182:497-508. (Pubitemid 30651047)
46. Yother J, Handsome GL, Briles DE. 1992. Truncated forms of PspA that are secreted from Streptococcus pneumoniae and their use in functional studies and cloning of the pspA gene. J. Bacteriol. 174:610-618.
47. Yuste J, et al. 2010. The effects of PspC on complement-mediated immunity to Streptococcus pneumoniae vary with strain background and capsular serotype. Infect. Immun. 78:283-292.
48. Zhang JR, et al. 2000. The polymeric immunoglobulin receptor translocates pneumococci across human nasopharyngeal epithelial cells. Cell 102: 827-837.